Revelation Biosciences IncHere is the public summary page for Revelation Biosciences Inc. Please login to see the complete information for Revelation Biosciences Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Revelation Biosciences Inc stacks up relative to its peers. |
| Darwin Score | -8 |
| Ticker | REVB |
| Latest Price | 2.50 USD as of close on 06-Aug-2025 |
| 3 Month price range | 2.24 to 10.44 USD |
| Market Capitalisation | 3.50Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California. See More ... |
| Company URL | https://www.revbiosciences.com |
| See Darwins Full Analysis for Revelation Biosciences Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Revelation Biosciences Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +8 |
| Sentiment | News and Candle Patterns. | +3 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +2 |
| Flow | Institutional, Fund and Insider buying and selling. | -4 |
| Models | Forecast models. | -17 |
Peer Comparison
There are 13 peers of Revelation Biosciences Inc.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Agenus Inc (AGEN) | Biotechnology | +28 |
| Alzamend Neuro Inc (ALZN) | Biotechnology | -21 |
| Athira Pharma Inc (ATHA) | Biotechnology | -4 |
| Cellectar Biosciences Inc (CLRB) | Biotechnology | -19 |
| GlycoMimetics Inc (GLYC) | Biotechnology | -64 |
| Imunon Inc (IMNN) | Biotechnology | -7 |
| Kiora Pharmaceuticals Inc (KPRX) | Biotechnology | -14 |
| Kronos Bio Inc (KRON) | Biotechnology | +8 |
| Lyra Therapeutics Inc (LYRA) | Biotechnology | +4 |
| Phio Pharmaceuticals Corp (PHIO) | Biotechnology | +20 |
| Plus Therapeutics Inc (PSTV) | Biotechnology | -8 |
| Tempest Therapeutics Inc (TPST) | Biotechnology | -16 |
| Turnstone Biologics Corp (TSBX) | Biotechnology | +10 |
Share 
